What they were paid
Tonix Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $55,000 | — | $188,830 | — | $243,830 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tonix Pharmaceuticals Holding Corp. DEF 14A filed March 30, 2026, accession 0001999371-26-007108, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Tonix Pharmaceuticals pays directors a $55,000 cash retainer and $188,830 in Options.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance (Chair)
The rest of the Tonix Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Adeoye Olukotun | Independent Director | $243,830 |
| Carolyn Taylor | Independent Director | $243,830 |
| David Grange | Independent Director | $243,830 |
| James Hunter | Independent Director | $280,207 |
| James Treco | Lead Independent Director | $263,830 |
| Margaret Smith Bell | Independent Director | $243,830 |
| Newcomb Stillwell | Independent Director | $243,830 |
| Seth Lederman | Chair of the Board | $0 |
The full Tonix Pharmaceuticals compensation record
free company briefThis page is one director within Tonix Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat